Literature DB >> 18278982

Reticulocytes in sports medicine.

Giuseppe Banfi1.   

Abstract

Reticulocytes are the transitional cells from erythroblasts to mature erythrocytes. Reticulocytes are present in blood for a period of 1-4 days and can be recognized by staining with supravital dyes, such as new methylene blue, or fluorescent markers, which couple residual nucleic acid molecules, a hallmark of the immature forms of erythrocytes. Although reticulocytes could be counted through a microscope (there is a standard of International Committee for Standardisation in Haematology for manual counting), this method is reported to be time consuming, inaccurate and imprecise. The integration of the reticulocyte count in automated haematology systems allowed the widespread use of these parameters, although the lack of calibration material and different markers, technologies and software used in automated systems could engender discrepancies among data obtained from different analytical systems.The importance of reticulocytes in sports medicine derives from their sensitivity, the highest among haematology parameters, in identifying the bone marrow stimulation, especially when recombinant human erythropoietin is fraudulently used. Automated systems are also able to supply information on volume, density and the haemoglobin content of reticulocytes. Some of the related parameters are also used in algorithms for identifying abnormal stimulation of bone marrow as reticulocytes haematocrit. The pre-analytical variability of reticulocytes (transportation, storage, biological variability) should be taken into account in sports medicine also. Reticulocytes remain stable for almost 24 hours at 4 degrees C from blood drawing, they are affected by transportation, and biological variability is not high in general. It could be remarked, however, that the intra-individual variability is high when compared with other haematological parameters such as haemoglobin and haematocrit. The intervals of data reported in athletes are very similar to reference intervals characterizing the general population.The reticulocyte count shows some modifications after training and during the competition season. The variability induced by exercise cannot be overlooked since the so-called haematological passport, a personal athlete's document in which haemoglobin and other parameters are registered, may be introduced by sports federations. Exposure to naturally high altitude and 'living high-training low' programmes determined contentious results on reticulocytes. Simulated high altitude induced by intermittent hypobaric hypoxia does not modify reticulocytes, despite an increase in erythropoietin serum concentration. The variability among athletes competing in different sport disciplines is apparently limited. The knowledge of the behaviour of reticulocytes in training and competitions is crucial for defining their role in an antidoping control context. It is important for sport physicians and clinical pathologists to know the reticulocyte variability in the general population and in athletes, the pre-analytical warnings, the different methodologies for counting reticulocytes and the derived parameters automatically available, and, finally, the possible influence of training, competitions, type of sport and altitude.

Entities:  

Mesh:

Year:  2008        PMID: 18278982     DOI: 10.2165/00007256-200838030-00002

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  79 in total

1.  Effects of a 12-day "live high, train low" camp on reticulocyte production and haemoglobin mass in elite female road cyclists.

Authors:  M J Ashenden; C J Gore; D T Martin; G P Dobson; A G Hahn
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1999-10

2.  Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.

Authors:  Michael J Ashenden; Christopher J Gore; Robin Parisotto; Ken Sharpe; Will G Hopkins; Allan G Hahn
Journal:  Haematologica       Date:  2003-09       Impact factor: 9.941

3.  Analysis of human reticulocyte genes reveals altered erythropoiesis: potential use to detect recombinant human erythropoietin doping.

Authors:  Emmanuelle Varlet-Marie; Michel Audran; Mireille Lejeune; Béatrice Bonafoux; Marie-Therese Sicart; Jacques Marti; David Piquemal; Thérèse Commes
Journal:  Haematologica       Date:  2004-08       Impact factor: 9.941

4.  The new reticulocyte parameter (RET-Y) of the Sysmex XE 2100: its use in the diagnosis and monitoring of posttreatment sideropenic anemia.

Authors:  Mauro Buttarello; Valeria Temporin; Renato Ceravolo; Giorgio Farina; Pietro Bulian
Journal:  Am J Clin Pathol       Date:  2004-04       Impact factor: 2.493

Review 5.  Managing transferability of laboratory data.

Authors:  Gian Cesare Guidi; Giuseppe Lippi; Giovanni Pietro Solero; Giovanni Poli; Mario Plebani
Journal:  Clin Chim Acta       Date:  2006-06-15       Impact factor: 3.786

6.  Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control.

Authors:  A Souillard; M Audran; F Bressolle; R Gareau; A Duvallet; J L Chanal
Journal:  Br J Clin Pharmacol       Date:  1996-09       Impact factor: 4.335

7.  Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties.

Authors:  W Schmidt; N Maassen; F Trost; D Böning
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1988

8.  The human reticulocyte transcriptome.

Authors:  Sung-Ho Goh; Matthew Josleyn; Y Terry Lee; Robert L Danner; Robert B Gherman; Maggie C Cam; Jeffery L Miller
Journal:  Physiol Genomics       Date:  2007-04-03       Impact factor: 3.107

9.  Analysis of red cell parameters on the Sysmex XE 2100 and ADVIA 120 in iron deficiency and in uraemic chronic disease.

Authors:  O David; A Grillo; B Ceoloni; F Cavallo; G Podda; P P Biancotti; D Bergamo; C Canavese
Journal:  Scand J Clin Lab Invest       Date:  2006       Impact factor: 1.713

10.  Live high-train low for 24 days increases hemoglobin mass and red cell volume in elite endurance athletes.

Authors:  Jon Peter Wehrlin; Peter Zuest; Jostein Hallén; Bernard Marti
Journal:  J Appl Physiol (1985)       Date:  2006-02-23
View more
  11 in total

Review 1.  Stability of haematological parameters and its relevance on the athlete's biological passport model.

Authors:  Giovanni Lombardi; Patrizia Lanteri; Alessandra Colombini; Giuseppe Lippi; Giuseppe Banfi
Journal:  Sports Med       Date:  2011-12-01       Impact factor: 11.136

Review 2.  [Counting reticulocytes: new importance of an old method].

Authors:  Hermann Heimpel; Heinz Diem; Thomas Nebe
Journal:  Med Klin (Munich)       Date:  2010-09-08

3.  Preanalytical variability: the dark side of the moon in blood doping screening.

Authors:  Giuseppe Lippi; Giuseppe Banfi; Nicola Maffulli
Journal:  Eur J Appl Physiol       Date:  2010-03-24       Impact factor: 3.078

4.  Reticulocyte profile in top-level alpine skiers during four consecutive competitive seasons.

Authors:  Giuseppe Banfi; Rodolfo Tavana; Marco Freschi; Carsten Lundby
Journal:  Eur J Appl Physiol       Date:  2010-02-12       Impact factor: 3.078

5.  Screening for recombinant human erythropoietin using [Hb], reticulocytes, the OFF(hr score), OFF(z score) and Hb(z score): status of the Blood Passport.

Authors:  Andreas Bornø; Niels J Aachmann-Andersen; Thor Munch-Andersen; Carl J Hulston; Carsten Lundby
Journal:  Eur J Appl Physiol       Date:  2010-02-02       Impact factor: 3.078

6.  Intermittent hypoxia mobilizes hematopoietic progenitors and augments cellular and humoral elements of innate immunity in adult men.

Authors:  Tatiana V Serebrovskaya; Igor S Nikolsky; Valentyna V Nikolska; Robert T Mallet; Vadim A Ishchuk
Journal:  High Alt Med Biol       Date:  2011       Impact factor: 1.981

7.  Hematologic and Biochemical Biologic Variation in Laboratory Cats.

Authors:  Catherine Trumel; Céline Monzali; Anne Geffré; Didier V Concordet; Louise Hourqueig; Jean-Pierre D Braun; Nathalie H Bourgès-Abella
Journal:  J Am Assoc Lab Anim Sci       Date:  2016       Impact factor: 1.232

8.  Haemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.

Authors:  Jérôme Durussel; Evangelia Daskalaki; Martin Anderson; Tushar Chatterji; Diresibachew H Wondimu; Neal Padmanabhan; Rajan K Patel; John D McClure; Yannis P Pitsiladis
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Hematological and biochemical markers of iron status in a male, young, physically active population.

Authors:  Lázaro Alessandro Soares Nunes; Helena Zerlotti W Grotto; René Brenzikofer; Denise Vaz Macedo
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

10.  Comparison of the hematological profile of elite road cyclists during the 2010 and 2012 GiroBio ten-day stage races and relationships with final ranking.

Authors:  Giovanni Lombardi; Patrizia Lanteri; Pier Luigi Fiorella; Luigi Simonetto; Franco M Impellizzeri; Marco Bonifazi; Giuseppe Banfi; Massimo Locatelli
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.